Navigation Links
Number of Uninsured in North Carolina on the Rise

The percentage of North Carolinians under the age of 65 who lacked health insurance for a year has risen from 15.3 percent in 2000 to 17.2 percent in 2005//. The proportion of uninsured residents ranged from a low of 13.4 percent in Wake County to a high of 27.5 percent in Tyrrell County.

Lack of health insurance is a particularly acute problem in Eastern North Carolina; nine of the 10 counties with the highest proportion of uninsured lie east of Interstate 95.

“County Estimates of the Number of Uninsured in North Carolina: A 2005 Update,” was released today (April 23, 2007) by the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill and the North Carolina Institute of Medicine. The report draws its estimates from two years of Current Population Survey data and includes rates for children under age 18 and adults 18 to 64.

“North Carolina has experienced a large decline in the percent of residents receiving health insurance from their employers. Although this trend is occurring across the nation, North Carolina's decline has been large compared to other states’,” said Mark Holmes, a Sheps Center senior research fellow and vice president of the North Carolina Institute of Medicine.

Holmes co-authored the study with Tom Ricketts, professor of health policy and administration in UNC’s School of Public Health and deputy director of Sheps.

The counties with the lowest rate of residents lacking health insurance coverage include Wake County, with 13.4 percent, followed by Orange County with 15 percent uninsured. Counties with a high proportion of their non-elderly residents lacking health insurance included Tyrrell, with 27.5 percent; Hyde, with 26.1 percent; and Greene, with 24.1 percent.

The uninsured are 25 percent more likely to die a premature death, Holmes said.

“Having access to estimates of the percent of local residents without health
'"/>




Page: 1 2

Related medicine news :

1. Reducing Number Of Cigarettes Not Enough
2. An Increase In Number Of Lung Cancer Deaths in Women
3. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
4. Number Of Babies Born Prematurely Nears Historic Half Million Mark In US
5. Smokers Are Prone To Number Of Psychiatric Disorders
6. AIDS Numbers Continue To Rise : WHO
7. WBSACS Says Number Of AIDS Cases On The Rise
8. Number Of Dementia Cases To Rise Drastically
9. Increase in the Number of Cases of Animal Diseases in New South Wales.
10. Record Number of Countries Contributed to UNFPA in 2005
11. Australia Witnesses A Fall In the Number of Organ Donors
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ies, those called up to risk their lives in the se...d even ill-treated. Apparently the US is no except... their grievances during a hearing of the Presiden...l at Washington on Saturday. Speaking from exper...
...euticals Incorporated, a global biotechnology comp...rial on new hepatitis C drug, telaprevir. The drug...t has been shown. The planned interim results of ...nnounced at Barcelona on Saturday at the 42nd Annu...
...ted pessimism hangs thickly over Britain’s junior ...th since UK’s young doctors took the street in pro...te of most of them having dished out thousands of ... that would make them eligible for NHS employment....
...ts at Bonn University have created a software syst...l implants significantly. //With the aid of the so... exactly those signals, which are expected and can...two dozens of patients in Germany and the U.S. hav...
Other Medicine News:Health News:Military Healthcare Lacks Compassion, Say US Soldiers 2Health News:New Hepatitis C Drug Shows Promise 2Health News:UK’s Junior Doctors Losing Hop 2Health News:Software System to Improve the Function of Retinal Implants 2Health News:Software System to Improve the Function of Retinal Implants 3
(Date:9/3/2008)...l Vascular Disease Awareness Month, CHARLOTTESVIL...euticals,LLC, a clinical-stage drug-development co...of unmet medical needs, announced today that it ha...l trial of its lead drug,candidate trans sodium cr...,on the clinicaltrials.gov Website, is investigati...
(Date:9/3/2008)...taq(R) (dronedarone) decreased the risk of,stroke ...al flutter already adequately treated...pt. 3 /- The results of a,p... were presented today at,the clinical trial update...gress 2008, in Munich, Germany. Previous results f...
(Date:9/3/2008)...s Strong Evidence Pycnogenol(R) Lowers Joint, Pain...Following Cessation of... -- According to the Center for,Disease Control (C...itis,is on the rise. A new study published in the...Pycnogenol(R), bark extract from the French mariti...
(Date:9/2/2008)...re-FirstCall/ -- Forest Laboratories, Inc.,(NYSE: ...nced results from,two global Phase III studies of ...ticholinergic for the treatment of patients with c...th the ACCLAIM/COPD I&II,(AClidinium CLinical Tria...ere COPD Patients) studies, once-daily aclidinium ...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 1AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 2AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 1Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 2Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 4Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 1Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 2Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 3Spiritual Healer Psychic Medium Reaches International Status 21 1230 1Spiritual Healer Psychic Medium Reaches International Status 21 1230 2
... Nasalfent shows clinically meaningful pain relief..., READING, England, 7 June 2007 - Archimedes Pharm...eutical company, today,presented new clinical data...ive fentanyl citrate nasal spray aimed at providin...reakthrough cancer,pain. Data were presented at th...
...Orexigen(TM) is evaluating zonisamide SR as a nove..., SAN DIEGO, June 07, 2007 /PRNewswire-FirstCall/ ...utical company focused on the,treatment of central... obesity, today announced results from a Phase I t... novel, proprietary,sustained-release (SR) formul...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
The MediLive ImageBox is the first, easy-to-use digital,recording device that integrates with the surgical microscope and video camera., ,It simplifies image capturing by burning the still imag
With MediLive MindStream you can make, cut and edit digital videos, add commentaries and notes, and save them. MediLive MindStream - intuitive user interface and high-resolution monitor all in one.
The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
...er Monitoring System, equipped with the latest Epi...is algorithm, Heart Rate Variability analysis and ...ith an Epicardia System in place have complete con...t their needs, and managing their data. The Epicar...
Medicine Products: